ARCHIVES

Perifosine Fails Primary Endpoint, Zentaris CEO Explores Options

This article is from The Cancer Letter archive.

Vol. 35 No. 4 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: After Nickles Removes Block, Senate Confirms Oncologist Henney As FDA Commissioner

October 23, 1998

Tucson Conference Could Be Lively

February 16, 1979

Brown Disagrees With Staff, Subgroup On Dichlorvos, Says It Is a Carcinogen

September 2, 1977

Litton Wins FCRF Research Contract, Harland Land Animal Protections

September 17, 1982

Gallo Breakthrough On AIDS Etiology To Be Reported Soon

April 20, 1984

Agency Approves Two Pairs Of Drugs and Diagnostic Tests

September 30, 2011